-Alfuzosin%20Structural%20Formula%20V2.svg)
alfuzosin
Sign in to saveAlfuzosin, sold under the brand name Uroxatral among others, is a medication of the α1 blocker class. It is used to treat benign prostatic hyperplasia (BPH).
Key facts
- Drug.H
- 27
- Drug.N
- 5
- Drug.O
- 4
- Drug.Watchedfields
- changed
- Drug.class
- α1 blocker
- Drug.verifiedrevid
- 477247048
- Drug.image
- Alfuzosin.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 275
- Drug.tradename
- Uroxatral, others
- Drug.MedlinePlus
- a64002
- Drug.DailyMedID
- Alfuzosin
- Drug.pregnancy_AU
- B2
- Drug.routes_of_administration
- By mouth
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
- Drug.bioavailability
- 49%
- Drug.protein_bound
- 82–90%
via Wikipedia infobox
Research
678 papers- Alfuzosin.2012
- Alfuzosin and Its Effect on Ejaculatory Dysfunction: A Systematic Review.The world journal of men's health · 2021
- Alfuzosin: a clinically uroselective alpha1-blocker.World journal of urology · 2002
- Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.Therapeutic advances in urology · 2021
- Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience.The Journal of urology · 2006
via PubMed
Article
11 sectionsContents
- Clinical information
- Side effects
- Indications for use
- Contraindications
- Pharmacological properties
- Chemistry
- Society and culture
- History
- Brand names
- Synthesis
- References
Alfuzosin, sold under the brand name Uroxatral among others, is a medication of the α1 blocker class. It is used to treat benign prostatic hyperplasia (BPH).
As an antagonist of the α1-adrenergic receptor, it works by relaxing the muscles in the prostate and bladder neck, making urination easier.